High bone marrow fat in patients with Cushing's syndrome and vertebral fractures

被引:22
作者
Ferrau, Francesco [1 ,2 ]
Giovinazzo, Salvatore [1 ]
Messina, Erika [1 ]
Tessitore, Agostino [3 ]
Vinci, Sergio [3 ,4 ]
Mazziotti, Gherardo [5 ,6 ]
Lania, Andrea [5 ,6 ]
Granata, Francesca [3 ,4 ]
Cannavo, Salvatore [1 ,2 ]
机构
[1] Univ Hosp AOU Policlin G Martino, Endocrine Unit, Messina, Italy
[2] Univ Messina, Dept Human Pathol Adulthood & Childhood G Barresi, Messina, Italy
[3] Univ Hosp AOU Policlin G Martino, Neuroradiol Unit, Messina, Italy
[4] Univ Messina, Dept Biomed Sci & Morphol & Funct Imaging, Messina, Italy
[5] Humanitas Univ, Dept Biomed Sci, Rozzano, MI, Italy
[6] Humanitas Clin & Res Ctr, Endocrine Unit, Rozzano, MI, Italy
关键词
Cushing's syndrome; Vertebral fractures; Bone marrow fat; Osteoporosis; Cortisol; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; BODY-COMPOSITION; PREVALENT; TURNOVER; DENSITY; DISEASE; SCORE; MASS; BMD; MICROARCHITECTURE;
D O I
10.1007/s12020-019-02034-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose The evaluation of skeletal fragility in Cushing's syndrome (CS) is a clinical challenge, since dual-energy X-ray absorptiometry (DXA) does not capture abnormalities in bone microstructure induced by glucocorticoid excess. Hyper-cortisolism was shown to increase bone marrow adiposity, but it is still unknown whether high bone marrow fat (BMF) as measured by vertebral magnetic resonance spectroscopy may predict fracture risk in this clinical setting. In this cross-sectional study, we evaluated the association between BMF and vertebral fractures (VFs) in patients with CS. Methods Twenty patients (5 M, age 44 +/- 13 years) with active CS were evaluated for morphometric VFs, lumbar spine BMF, and bone mineral density (BMD). Fifteen healthy volunteers (4 M, age 43 +/- 12 years) acted as control group for BMF evaluation. Results BMF was significantly higher in CS patients vs. controls (52.0% vs. 27.0%, p < 0.01), and was directly correlated with patients' age (p = 0.03), 24-hours urine-free cortisol (p = 0.03), midnight serum cortisol (p = 0.02), and serum CTX (p = 0.01). Patients with VFs (13 cases) showed significantly higher BMF vs. patients without VFs (65.0% vs. 24.0%, p = 0.03). Fractured patients with either normal BMD or osteopenia showed comparable BMF to fractured patients with either osteoporosis or low BMD for age (p = 0.71). When the analysis was restricted to patients with normal BMD or osteopenia, VFs were still significantly associated with higher BMF (p = 0.05). Conclusions This study provides a first evidence that vertebral adiposity may be a marker of hypercortisolism-induced skeletal fragility and measurement of spine BMF could have a role in the diagnostic work-up for the assessment of fracture risk in CS.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 50 条
  • [31] Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome
    Vena, W.
    Carrone, F.
    Delbarba, A.
    Akpojiyovbi, O.
    Pezzaioli, L. C.
    Facondo, P.
    Cappelli, C.
    Leonardi, L.
    Balzarini, L.
    Farina, D.
    Pizzocaro, A.
    Lania, A. G.
    Mazziotti, G.
    Ferlin, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (02) : 297 - 304
  • [32] Prediction of Vertebral Fractures by Trabecular Bone Score in Patients With Ankylosing Spondylitis
    Killinger, Zdenko
    Kuzma, Martin
    Tomkova, Sona
    Brazdilova, Kristina
    Jackuliak, Peter
    Payer, Juraj
    PHYSIOLOGICAL RESEARCH, 2021, 70 : S53 - S60
  • [33] Lower extremity insufficiency fractures: an underappreciated manifestation of endogenous Cushing's syndrome
    Poonuru, S.
    Findling, J. W.
    Shaker, J. L.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (12) : 3645 - 3649
  • [34] The Severity of Bone Loss: A Comparison Between Cushing's Disease and Cushing's Syndrome
    Naguib, Rania
    Elkemary, Eman Z.
    Elsharkawi, Karim Mohamed
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2023, 13 (01) : 33 - 38
  • [35] Cortical bone density and thickness alterations by high-resolution peripheral quantitative computed tomography: association with vertebral fractures in primary Sjogren's syndrome
    Pasoto, Sandra G.
    Augusto, Kristopherson L.
    Alvarenga, Jackeline C.
    Takayama, Liliam
    Oliveira, Ricardo M.
    Bonfa, Eloisa
    Pereira, Rosa M. R.
    RHEUMATOLOGY, 2016, 55 (12) : 2200 - 2211
  • [36] Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes
    Yamaguchi, Toru
    Kanazawa, Ippei
    Yamamoto, Masahiro
    Kurioka, Soichi
    Yamauchi, Mika
    Yano, Shozo
    Sugimoto, Toshitsugu
    BONE, 2009, 45 (02) : 174 - 179
  • [37] Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome
    Sbrocchi, Anne Marie
    Rauch, Frank
    Matzinger, MaryAnn
    Feber, Janusz
    Ward, Leanne M.
    PEDIATRIC NEPHROLOGY, 2011, 26 (01) : 139 - 142
  • [38] Bone quality, vertebral fragility fractures and intervertebral disc calcifications in patients with transfusion-dependent β-thalassem'a
    de Sire, Alessandro
    Invernizzi, Marco
    Moretti, Antimo
    Curci, Claudio
    Toro, Giuseppe
    Casale, Maddalena
    Perrotta, Silverio
    Gimigliano, Francesca
    Iolascon, Giovanni
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2019, 16 (02) : 111 - 115
  • [39] Associations between trabecular bone score and vertebral fractures in patients with axial spondyloarthritis
    Kang, Kwi Young
    Kim, In Je
    Park, Sung-Hwan
    Hong, Yeon Sik
    RHEUMATOLOGY, 2018, 57 (06) : 1033 - 1040
  • [40] Circulating Sclerostin Associated With Vertebral Bone Marrow Fat in Older Men But Not Women
    Ma, Yu-Heng Vivian
    Schwartz, Ann V.
    Sigurdsson, Sigurdur
    Hue, Trisha F.
    Lang, Thomas F.
    Harris, Tamara B.
    Rosen, Clifford J.
    Vittinghoff, Eric
    Eiriksdottir, Gudny
    Hauksdottir, Alda M.
    Siggeirsdottir, Kristin
    Sigurdsson, Gunnar
    Oskarsdottir, Diana
    Napoli, Nicola
    Palermo, Lisa
    Gudnason, Vilmundur
    Li, Xiaojuan
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (12) : E2584 - E2590